Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

NVNO stock hub

enVVeno Medical Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NVNOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NVNO

In the news

Latest news · NVNO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-60.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-39.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NVNO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

USD

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001661053
Company name	enVVeno Medical Corporation
Country	United States
Country code	US
Cusip	29415J106
Employees	33
Employees Change	-4%
Employees Change Percent	-10.81
Enterprise value	$-17.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US29415J2050
Last refreshed	2026-05-10
Market cap	$6.5M
Market cap category	Nano-Cap
Price	$9.94
Price currency	USD
Sector	Healthcare
Sic	3841
Symbol	NVNO
Website	https://www.envveno.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-288.8%
FCF yield	-227.03%
P/B ratio	0.27x
PS Forward	0.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-18.8M
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Profit Per Employee	$-570,242
ROA	-37.51
Roa5y	-32.83
ROCE	-83.52
ROE	-60.65
Roe5y	-53.54
ROIC	-39.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-92.48%
Cagr3y	-57.38%
Cagr5y	-44.86%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$26.1M
Cash	$24.9M
Current Assets	$25.5M
Current Liabilities	$2.1M
Debt	$603,000
Debt Equity	$0.03
Equity	$23.7M
Liabilities	$2.4M
Long Term Assets	$608,000
Long Term Liabilities	$207,000
Net Cash	$24.3M
Net Cash By Market Cap	$373
Net Cash Growth	-35.92%
Net Debt Equity	$-1.02
Tangible Book Value	$23.7M
Tangible Book Value Per Share	$36.2
WACC	9.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.89
Net Working Capital	$-1.2M
Quick ratio	11.63
Working Capital	$23.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.65%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-92.47%
200-day SMA	32.27
3Y total return	-92.26%
50-day SMA	11.09
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.9%
All Time High	4,935
All Time High Change	-99.8%
All Time High Date	2018-05-31
All Time Low	8.67
All Time Low Change	14.65%
All Time Low Date	2026-02-17
ATR	0.77
Beta	1.08
Beta1y	2.19
Beta2y	1.74
Ch YTD	-11.47
High	10.25
High52	196.7
High52 Date	2025-07-17
High52ch	-94.95%
Low	9.92
Low52	8.67
Low52 Date	2026-02-17
Low52ch	14.65%
Ma50ch	-10.39%
Price vs 200-day SMA	-69.2%
RSI	38.06
RSI Monthly	32.55
RSI Weekly	32.78
Sharpe ratio	-1.25x
Sortino ratio	-1.44
Total Return	-16.65%
Tr YTD	-11.47
Tr1m	-3.78%
Tr1w	-5.33%
Tr3m	-4.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-20M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	473,920%
Float Percent	72.3%
Shares Insiders	9.07%
Shares Institutions	11.01%
Shares Out	655,521
Shares Qo Q	5.96%
Shares Yo Y	16.65%
Short Float	16.07%
Short Ratio	7.76
Short Shares	11.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-18M
Average Volume	11,122.65x
Bv Per Share	36.2
CAPEX	$-5,000
Ch1m	-3.78
Ch1w	-5.33
Ch1y	-92.47
Ch3m	-4.61
Ch3y	-92.26
Ch5y	-94.9
Ch6m	-56.19
Change	-2.74%
Change From Open	-3.02
Close	10.22
Days Gap	0.29
Depreciation Amortization	127,000
Dollar Volume	59,719.5
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$-20M
EBITDA	$-19.9M
EPS	$-30.99
F Score	1
FCF	$-14.8M
FCF EV Yield	83.05x
FCF Per Share	$-22.57
Financing CF	1,023,000
Fiscal Year End	December
Founded	1,987
Investing CF	13,425,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2026-01-20
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	14.47
Ma150ch	-31.29%
Ma20	11.35
Ma20ch	-12.38%
Net CF	-340,000
Next Earnings Date	2026-07-30
Open	10.25
Optionable	Yes
Position In Range	6.06
Post Close	9.94
Postmarket Change Percent	0.1
Postmarket Price	$9.95
Ppne	577,000
Price Date	2026-05-08
Ptbv Ratio	0.27
Relative Volume	0.54x
Share Based Comp	3,236,000
Tr6m	-56.19%
Us State	California
Volume	6,008

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NVNO pay a dividend?

Capital-return profile for this ticker.

Performance

NVNO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NVNO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.0%

Float: +72.3% of shares outstanding

Insider ownership

+9.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NVNO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.1

Neutral momentum band

Price vs 200-day MA

-69.2%

50/200-day relationship not available

Beta (5Y)

1.08

Moves roughly with the market

Sharpe ratio

-1.25

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NVNO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NVNO stock rating?

enVVeno Medical Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NVNO analysis?

The full report lives at /stocks/NVNO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NVNO?

The latest report frames NVNO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NVNO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.